BioFlyte, Inc. is a biotechnology startup founded in 2020 with the slogan "BioThreat Security at Scale." The company focuses on commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. BioFlyte, Inc. is headquartered in the United States.
The company recently secured a $5.40M Series B investment on 10 August 2023, with participation from Scout Ventures, Cottonwood Technology Fund, NM Vintage Fund.
With its innovative approach to biothreat security and the backing of notable investors, BioFlyte, Inc. is poised to make significant strides in the biotechnology industry, leveraging its cutting-edge technology and strong financial support for future growth and development.
No recent news or press coverage available for BioFlyte, Inc..